Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
2.070
+0.050 (2.48%)
Dec 5, 2025, 4:00 PM EST - Market closed
Inovio Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 142 | 66 | 139 | 389 | 1,050 | 1,499 | |
| Market Cap Growth | 33.66% | -52.55% | -64.23% | -62.93% | -29.98% | 354.28% | |
| Enterprise Value | 101 | -6 | 2 | 140 | 688 | 1,237 | |
| Last Close Price | 2.07 | 1.83 | 6.12 | 18.72 | 59.88 | 106.20 | |
| PS Ratio | 779.96 | 303.38 | 167.33 | 37.93 | 591.53 | 202.30 | |
| PB Ratio | - | 0.96 | 1.19 | 1.75 | 2.63 | 3.25 | |
| P/TBV Ratio | - | 0.96 | 1.19 | 1.86 | 2.72 | 3.35 | |
| EV/Sales Ratio | 556.29 | - | 1.86 | 13.62 | 387.68 | 166.88 | |
| Debt / Equity Ratio | -1.30 | 0.17 | 0.26 | 0.14 | 0.08 | 0.09 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.02 | |
| Quick Ratio | 0.74 | 2.70 | 3.47 | 2.73 | 6.23 | 10.33 | |
| Current Ratio | 0.79 | 2.77 | 3.60 | 3.25 | 6.82 | 11.30 | |
| Return on Equity (ROE) | -328.45% | -115.42% | -79.55% | -89.97% | -70.55% | -71.79% | |
| Return on Assets (ROA) | -63.56% | -49.45% | -30.50% | -37.53% | -36.35% | -22.68% | |
| Return on Capital (ROIC) | -127.02% | -61.64% | -39.41% | -46.13% | -40.36% | -25.63% | |
| Return on Capital Employed (ROCE) | 20471.70% | -144.30% | -98.70% | -100.80% | -70.00% | -24.90% | |
| Earnings Yield | -76.01% | -162.35% | -97.05% | -71.89% | -28.93% | -11.10% | |
| FCF Yield | -62.64% | -158.28% | -89.56% | -55.80% | -20.66% | -11.97% | |
| Buyback Yield / Dilution | -53.38% | -22.49% | -11.51% | -14.27% | -34.62% | -57.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.